Natco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celgene, now part of Bristol-Myers Squibb, who sells the product under the brand name ‘Revlimid’, it added.
Copyright © 2024 | WordPress Theme by MH Themes